Halogen bonding (X-bonding): A biological perspective

Protein Science

Volumn 22, Issue 2, 2013, Pages 139-152

  Scholfield, Matthew R ^a   Vander Zanden, Crystal M ^a   Carter, Megan ^a   Ho, P Shing ^a  

^a Veterinary Dentistry and Oral Surgery   (United States)

Author keywords

Drug design; Halogen bond; Molecular recognition; Protein inhibitor complexes

Indexed keywords

FLAME RETARDANT; HALIDE; HALOGEN; HYDROGEN; LEWIS BASE; PROTEIN KINASE; THYROID HORMONE;

CARCINOGENESIS; CHEMICAL BINDING; COVALENT BOND; DENSITY FUNCTIONAL THEORY; ELECTRON; HALOGEN BONDING; HEALTH HAZARD; HYDROGEN BOND; MOLECULAR INTERACTION; MOLECULAR RECOGNITION; POLARIZATION; PRIORITY JOURNAL; QUANTUM MECHANICS; REVIEW;

BINDING SITES; BIOLOGICAL FACTORS; HALOGENS; MODELS, MOLECULAR;

EID: 84874046410     PISSN: 09618368     EISSN: 1469896X     Source Type: Journal    
DOI: 10.1002/pro.2201     Document Type: Review

References (76)

1. Guthries F (1863) On the iodide of iodammonium. J Am Chem Soc 16:239-244.
2. Hassel O (1970) Scinece, 17, 497-502.
3. Lommerse JPM, Stone AJ, Taylor R, Allen FH (1996) The nature and geometry of intramolecular interactions between halogens and oxygen or nitrogen. J Am Chem Soc 118:3108-3116.
4. Legon AC (1999) Prereactive complexes of dihalogens XY with Lewis bases B in the gas phase: a systematic case for the halogen analogue B-XY of the hydrogen bond B-HX. Angew Chem Int Ed Engl 38:2686-2714.
5. Metrangolo P, Neukirch H, Pilati T, Resnati G (2005) Halogen bonding based recognition processes: a world parallel to hydrogen bonding. Acc Chem Res 38: 386-395.
6. Hays FA, Vargason JM, Ho PS (2003) Effect of sequence on the conformation of DNA Holliday junctions. Biochemistry 42:9586-9597.
7. Howard EI, Sanishvili R, Cachau RE, Mitschler A, Chevrier B, Barth P, Lamour V, Van Zandt M, Sibley E, Bon C, Moras D, Schneider TR, Joachimiak A, Podjarny A (2004) Ultrahigh resolution drug design I: details of interactions in human aldose reductase-inhibitor complex at 0.66 A. Proteins 55:792-804.
8. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE (2000) The Protein Data Bank. Nucleic Acids Res 28:235-242.
9. Auffinger P, Hayes FA, Westhof E, Ho PS (2004) Halogen bonds in biological molecules. Proc Natl Acad Sci USA 101:16789-16794.
10. Lam PYS, Clark CG, Smallwood AM, Alexander RS (2009) Structure-based drug design utilizing halogen bonding: factor Xa inhibitors. In: The 238th ACS National Meeting, Metrangolo P, Resnati G, Eds., Washington, DC: ACS, p 58.
11. Metrangolo P, Resnati G (2001) Halogen bonding: a paradigm in supramolecular chemistry. Chemistry 7: 2511-2519.
12. Politzer P, Murray JS, Concha MC (2007) Halogen bonding and the design of new materials: organic bromides, chlorides and perhaps even fluorides as donors. J Mol Model 13:643-650.
13. Fourmigu-e M (2009) Halogen bonding: recent advances. Curr Opin Solid State Mat Sci 13:36-45.
14. Scott ME, Viola RE (1998) The use of fluoro-and deoxy-substrate analogs to examine binding specificity and catalysis in the enzymes of the sorbitol pathway. Carbohydr Res 313:247-253.
15. Brinck T, Murray JS, Politzer P (1992) Surface electrostatic potentials of halogenated methanes as indicators of directional intermolecular interactions. Int J Quantum Chem 44:57-64.
16. Murray JS, Lane P, Clark T, Politzer P (2007) Sigmahole bonding: molecules containing group VI atoms. J Mol Model 13:1033-1038.
17. Clark T, Hennemann M, Murray JS, Politzer P (2007) Halogen bonding: the sigma-hole. Proceedings of ''Modeling interactions in biomolecules II'', Prague, September 5th-9th, 2005. J Mol Model 13:291-296.
18. Politzer P, Murray JS, Lane P (2007) Sigma-hole bonding and hydrogen bonding: competitive interactions. Int J Quantum Chem 107:3046-3052.
19. Lu Y, Wang Y, Xu Z, Yan X, Luo X, Jiang H, Zhu W (2009) C-X. . .H contacts in biomolecular systems: how they contribute to protein-ligand binding affinity. J Phys Chem B 113:12615-12621.
20. Nyburg S (1979) Polar flattening: non-spherical effective shapes of atoms in crystals. Acta Cryst A35:641-645.
21. Peebles SA, Fowler PW, Legon AC (1995) Anisotropic repulsion in complexes B-Cl-2 and B-Hcl-the shape of the chlorine atom-in-a-molecule. Chem Phys Lett 240:130-134.
22. Carter M, Rappe AK, Ho PS (2012) Scalable anisotroplic shape and electrostatic models for biological bromine halogen bonds. J Chem Theory Comput 8: 2461-2473.
23. Riley KE, Murray JS, Politzer P, Concha MC, Hobza P (2009) Br-O complexes as probes of factors affecting halogen bonding: interactions of bromobenzenes and bromopyrimidines with acetone. J Chem Theory Comput 5:155-163.
24. Riley KE, Hobza P (2008) Investigations into the nature of halogen bonding including symmetry adapted perturbation theory analyses. J Chem Theory Comput 4:232-242.
25. Wu JY, Zhang JC, Wang ZX, Cao WL (2007) Theoretical study on intermolecular interactions in BrF/HnX adducts. Chem Phys 338:69-74.
26. Riley KE, Hobza P (2011) Strength and character of halogen bonds in protein-ligand complexes. Crystal Growth Des 11:4272-4278.
27. Lu YX, Zou JW, Wang YH, Jiang YJ, Yu QS (2007) Ab initio investigation of the complexes between bromobenzene and several electron donors: some insights into the magnitude and nature of halogen bonding interactions. J Phys Chem 111:10781-10788.
28. Murray JS, Riley KE, Politzer P, Clark T (2010) Directional weak intermolecular interactions: sigma-hole bonding. Aust J Chem 63:1598-1607.
29. Ouvrard C, Le Questel JY, Berthelot M, Laurence C (2003) Halogen-bond geometry: a crystallographic database investigation of dihalogen complexes. Acta Cryst B 59:512-526.
30. Prasanna MD, Guru Row TN (2000) C-halogen-p interactions and their influence on molecular conformation and crystal packing: a database study. Crystal Eng 3:135-154.
31. Voth AR, Ho PS (2007) The role of halogen bonding in inhibitor recognition and binding by protein kinases. Curr Top Med Chem 7:1336-1348.
32. Matter H, Nazare M, Gussregen S, Will DW, Schreuder H, Bauer A, Urmann M, Ritter K, Wagner M, Wehner V (2009) Evidence for C-Cl/C-Br. . .pi interactions as an important contribution to protein-ligand binding affinity. Angew Chem Int Ed Engl 48:2911-2916.
33. Steiner T, Koellner G (2001) Hydrogen bonds with piacceptors in proteins: frequencies and role in stabilizing local 3D structures. J Mol Biol 305:535-557.
34. Voth AR, Khuu P, Oishi K, Ho PS (2009) Halogen bonds as orthogonal molecular interactions to hydrogen bonds. Nat Chem 1:74-79.
35. Egner U, Kratzschmar J, Kreft B, Pohlenz HD, Schneider M (2005) The target discovery process. Chembiochem 6:468-479.
36. Riley KE, Murray JS, Fanfrlik J, Rezac J, Sola RJ, Concha MC, Ramos FM, Politzer P (2011) Halogen bond tunability I: the effects of aromatic fluorine substitution on the strengths of halogen-bonding interactions involving chlorine, bromine, and iodine. J Mol Model 17:3309-3318.
37. Voth AR, Hays FA, Ho PS (2007) Directing macromolecular conformation by halogen bonds. Proc Natl Acad Sci USA 104:6188-6193.
38. Carter M, Ho PS (2011) Assaying the energies of biological halogen bonds. Cryst Growth Des 11:5087-5095.
39. Lu Y, Wang Y, Xu Z, Yan X, Luo X, Jiang H, Zhu W (2009) C-X. . .H contacts in biomolecular systems: how they contribute to protein-ligand binding affinity. J Phys Chem B 113:12615-12621.
40. Vallejos M, Auffinger P, Ho P (2012) Halogen interactions in biomolecular crystal structures, in International Tables of Crystallography, Volume F, 2nd ed., Ch 23.6, Himmel DM and Rossman MG, eds., Hoboken, NJ: Wiley
41. Sunami T, Kondo J, Hirao I, Watanabe K, Miura K, Takenaka A (2004) Structures of d(GCGAAGC) and d(GCGAAAGC) (tetragonal form): a switching of partners of the sheared G.A pairs to form a functional G.AxA.G crossing. Acta Cryst D60:422-431.
42. Sunami T, Kondo J, Hirao I, Watanabe K, Miura KI, Takenaka A (2004) Structure of d(GCGAAAGC) (hexagonal form): a base-intercalated duplex as a stable structure. Acta Cryst D60:90-96.
43. Gribble GW (2003) The diversity of naturally produced organohalogens. Chemosphere 52:289-297.
44. Eneqvist T, Lundberg E, Karlsson A, Huang S, Santos CR, Power DM, Sauer-Eriksson AE (2004) High resolution crystal structures of piscine transthyretin reveal different binding modes for triiodothyronine and thyroxine. J Biol Chem 279:26411-26416.
45. Valadares NF, Salum LB, Polikarpov I, Andricopulo AD, Garratt RC (2009) Role of halogen bonds in thyroid hormone receptor selectivity: pharmacophore-based 3DQSSR studies. J Chem Inf Model 49:2606-2616.
46. Johnson SM, Connelly S, Wilson IA, Kelly JW (2008) Biochemical and structural evaluation of highly selective 2-arylbenzoxazole-based transthyretin amyloidogenesis inhibitors. J Med Chem 51:260-270.
47. Nascimento AS, Dias SM, Nunes FM, Aparicio R, Ambrosio AL, Bleicher L, Figueira AC, Santos MA, de Oliveira Neto M, Fischer H, Togashi M, Craievich AF, Garratt RC, Baxter JD, Webb P, Polikarpov I (2006) Structural rearrangements in the thyroid hormone receptor hinge domain and their putative role in the receptor function. J Mol Biol 360:586-598.
48. Levesque D, Beaudoin JD, Roy, S, Perreault JP (2007) In vitro selection and characterization of RNA aptamers binding thyroxine hormone. Biochem J 403:129-138.
49. McTamney PM, Rokita SE (2009) A mammalian reductive deiodinase has broad power to dehalogenate chlorinated and brominated substrates. J Am Chem Soc 131: 14212-14213.
50. Manna D, Mugesh G (2012) Regioselective deiodination of thyroxine by iodothyronine deiodinase mimics: an unusual mechanistic pathway involving cooperative chalcogen and halogen bonding. J Am Chem Soc 134: 4269-4279.
51. Liao JJL (2007) Molecular recognition of protein kinase binding pockets for design of potent and selective kinase inhibitors. J Med Chem 50:409-424.
52. Heald RA, Jackson P, Savy P, Jones M, Gancia E, Burton B, Newman R, Boggs J, Chan E, Chan J, Choo E, Merchang M, Rudewicz P, Ultsch M, Wiesmann C, Yue Q, Belvin M, Price S (2012) Discovery of novel allosteric mitogen-activated protein kinase kinase (MEK) 1,2 inhibitors possessing bidentate Ser212 interactions. J Med Chem 55:4594-4604.
53. Fedorov O, Huber K, Eisenreich A, Filippakopoulos P, King O, Bullock AN, Szklarczyk D, Jensen LJ, Fabbro D, Trappe J, Rauch U, Bracher F, Knapp S (2011) Specific CLK inhibitors from a novel chemotype for regulation of alternative splicing. Chem Biol 18:67-76.
54. Yun CH, Boggon TJ, Li YQ, Woo MS, Greulich H, Meyerson M, Eck MJ (2007) Structures of lung cancerderived EGFR mutants and inhibitor complexes: mechanism of activation and insights into differential inhibitor sensitivity. Cancer Cell 11:217-227.
55. Maiereanu C, Schmitt C, Schifano-Faux N, Le Nouen D, Defoin A, Tarnus C (2011) A novel amino-benzosuberone derivative is a picomolar inhibitor of mammalian aminopeptidase N/CD13. Bioorg Med Chem 19: 5716-5733.
56. Hammami M, RuhmannE, Maurer E, Heine A, Gutschow M, Klebe G, Steinmetzer T (2012) New 3-amidinophenylalanine-derived inhibitors of matriptase. Medchemcomm 3:807-813.
57. Wilcken R, Liu X, ZImmermann MO, Rutherford TJ, Fersht AR, Joerger AC, Boeckler FM (2012) Halogenenriched fragment libraries as leads for drug rescue of mutant p53. J Am Chem Soc 134:6810-6818.
58. Carpenter RD, Natarajan A, Lau EY, Andrei M, Solano DM, Lightstone FC, DeNardo SJ, Lam KS, Kurth MJ (2010) Halogenated benzimidazole carboxamides target integrin alpha(4)beta(1) on T-cell and B-bell lymphomas. Cancer Res 70:5448-5456.
59. Corradi E, Meille SV, Messina MT, Metrangolo P, Resnati G (2000) Halogen bonding versus hydrogen bonding in driving self-assembly processes. Angew Chem Int Ed 39:1782-1786.
60. Liu L, Baase WA, Matthews BW (2009) Halogenated benzenes bound within a non-polar cavity in T4 lysozyme provide examples of I. . .S and I. . .Se halogen-bonding. J Mol Biol 385:595-605.
61. Hardegger LA, Kuhn B, Spinnler B, Anselm L, Ecabert R, Stihle M, Gsell B, Thoma R, Diez J, Benz J, Plancher JM, Hartmann G, Banner DW, Haap W, Diederich F (2011) Systematic investigation of halogen bonding in protein-ligand interactions. Angew Chem Int Ed Engl 50:314-318.
62. Hardegger LA, Kuhn B, Spinnler B, Anselm L, Ecabert R, Stihle M, Gsell B, Thoma R, Diez J, Benz J, Plancher JM, Hartmann G, Isshiki Y, Morikami K, Shimma N, Haap W, Banner DW, Diederich F (2011) Halogen bonding at the active sites of human cathepsin L and MEK1 kinase: efficient interactions in different environments. ChemMedChem 6:2048-2054.
63. Wyatt PG, Woodhead AJ, Berdini V, Boulstridge JA, Carr MG, Cross DM, Davis DJ, Devine LA, Early TR, Feltell RE, Lewis EJ, McMenamin RL, Navarro EF, O'Brian MA, O'Reilly M, Reule M, Saxty G, Seavers LC, Smith DM, Squires MS, Trewartha G, Walker MT, Woolford AJ (2008) Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H-pyrazole-3-carboxamide (AT7519), a novel cyclin dependent kinase inhibitor using fragment-based X-ray crystallography and structure based drug design. J Med Chem 51:4986-4999.
64. Battistutta R, Mazzorana M, Cendron L, Bortolato A, Sarno S, Kazimierczuk Z, Zanotti G, Moro S, Pinna LA (2007) The ATP-binding site of protein kinase CK2holds a positive electrostatic area and conserved water molecules. Chembiochem 8:1804-1809.
65. Muzet N, Guillot B, Jelsch C, Howard E, Lecomte C (2003) Electrostatic complementarity in an aldose reductase complex from ultra-high-resolution crystallography and first-principles calculations. Proc Natl Acad Sci USA 100:8742-8747.
66. Kollman PA, Weiner S, Seibel G, Lybrand T, Singh UC, Caldwell J, Rao SN (1986) Modeling complex molecular interactions involving proteins and DNA. Ann NY Acad Sci 482:234-244.
67. Vreven T, Morokuma K, Farkas O, Schlegel HB, Frisch MJ (2003) Geometry optimization with QM/MM, ONIOM, and other combined methods. I. Microiterations and constraints. J Comput Chem 24:760-769.
68. Lu YX, Shi T, Wang Y, Yang HY, Yan XH, Luo XM, Jiang HL, Zhu WL (2009) Halogen Bonding-A Novel Interaction for Rational Drug Design? J Med Chem 52: 2854-2862.
69. Case DA, Cheatham 3rd TE, Darden T, Gohlke H, Luo R, Merz KM, Jr, Onufriev A, Simmerling C, Wang B, Woods RJ (2005) The Amber biomolecular simulation programs. J Comput Chem 26:1668-1688.
70. Jorgensen WL, Schyman P (2012) Treatment of halogen bonding in the OPLS-AA force field: application to potent anti-HIV agents. J Chem Theory Comput 8:3895-3901.
71. Ibrahim MAA (2011) Molecular mechanical study of halogen bonding in drug discovery. J Comput Chem 32: 2564-2574.
72. Ibrahim MA (2012) AMBER empirical potential describes the geometry and energy of noncovalent halogen interactions better than advanced semiempirical quantum mechanical method PM6-DH2X. J Phys Chem B 116:3659-3669.
73. Kolar M, Hobza P (2012) On extension of the current biomolecular empirical force field for the description of halogen bonds. J Chem Theory Comput 8:1325-1333.
74. Schulz WG (2012) Ablaze over furniture fires. Chem Eng News 90:28-33.
75. Hogue C (2012) EPA targets flame retardants. Chem Eng News 90:34-37.
76. Tiwari A, Panigrahi SK (2007) HBAT: a complete package for analysing strong and weak hydrogen bonds in macromolecular crystal structures. In Silico Biol 7:0057.